SCHEMBL7100697

SCHEMBL7100697

CC1(C)CC(=O)C2=C(C1)NC1=C(C(=O)OC1)C2c1ccccc1C(F)(F)F

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 10/20 0.60
GSK3A P49840 8/20 0.60
ACHE P22303 1/20 0.46
CDK5 Q00535 2/20 0.46
ALDH1A1 P00352 4/20 0.45
TSHR P16473 1/20 0.45
KDM4E B2RXH2 1/20 0.43
GAA P10253 1/20 0.43
HPGD P15428 1/20 0.43
CASP1 P29466 1/20 0.43
CASP7 P55210 1/20 0.43
HSD17B10 Q99714 1/20 0.43
CDK1 P06493 1/20 0.43
CDK2 P24941 1/20 0.43
CSNK1D P48730 1/20 0.43
PBK Q96KB5 1/20 0.43
MEN1 O00255 1/20 0.41
LMNA P02545 1/20 0.41
MAPT P10636 1/20 0.41
MAPK1 P28482 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7102178 0.87 ALDH1A1 (0.48) GSK3BGSK3AALDH1A1KDM4EGAA
SCHEMBL5813926 0.83 GSK3B (0.58) GSK3BGSK3ACDK5ALDH1A1TSHR
SCHEMBL7094392 0.81 GSK3B (0.64) GSK3BGSK3ACDK5ALDH1A1TSHR
SCHEMBL7099662 0.80 MAPT (0.61) GSK3BGSK3AACHEALDH1A1TSHR
SCHEMBL7188663 0.80 ALDH1A1 (0.52) GSK3BGSK3ACDK5ALDH1A1TSHR
SCHEMBL5219391 0.80 GSK3B (0.62) GSK3BGSK3AALDH1A1TSHRKDM4E
SCHEMBL10817848 0.79 ALDH1A1 (0.46) GSK3BGSK3AALDH1A1TSHRKDM4E
SCHEMBL12135862 0.76 MAPT (0.54) GSK3BGSK3AALDH1A1TSHRKDM4E
SCHEMBL16479064 0.75 GSK3B (1.00) GSK3BGSK3ACDK5TSHRKDM4E
SCHEMBL16479109 0.75 GSK3A (1.00) GSK3BGSK3ACDK5CDK1CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1278746-A2 DIHYDROPYRIDINE COMPOUNDS AND METHODS OF USE Abbott Laboratories (US) 2003-01-29 EP claimed
WO-2001083480-A2 DIHYDROPYRIDINE COMPOUNDS AND METHODS OF USE ABBOTT LABORATORIES (US) 2001-11-08 WO claimed
EP-1131322-A2 DIHYDROPYRIDINE COMPOUNDS AND METHODS OF USE ABBOTT LABORATORIES (US) 2001-09-12 EP claimed
WO-2000024741-A2 DIHYDROPYRIDINE COMPOUNDS AND THEIR USE AS POTASSIUM CHANNEL OPENERS ABBOTT LABORATORIES (US) 2000-05-04 WO claimed
EP-1278746-A2 DIHYDROPYRIDINE COMPOUNDS AND METHODS OF USE Abbott Laboratories (US) 2003-01-29 EP disclosed
WO-2001083480-A2 DIHYDROPYRIDINE COMPOUNDS AND METHODS OF USE ABBOTT LABORATORIES (US) 2001-11-08 WO disclosed
EP-1131322-A2 DIHYDROPYRIDINE COMPOUNDS AND METHODS OF USE ABBOTT LABORATORIES (US) 2001-09-12 EP disclosed
WO-2000024741-A2 DIHYDROPYRIDINE COMPOUNDS AND THEIR USE AS POTASSIUM CHANNEL OPENERS ABBOTT LABORATORIES (US) 2000-05-04 WO disclosed